Gene · 2188
FANCF: FA complementation group F
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FANCF: FA complementation group F. Genes, record 2188. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2188
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NPI8 | Fanconi anemia group F protein | 374 | 7 | Ensembl, GeneID, HGNC |
Source UniProt
Patents26
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 45846 | Q9NPI8 | Espacenet |
| US 11976334 B2 | 2024-05-07 | 150 | Q9NPI8 | Espacenet |
| EP 4268831 A2 | 2023-11-01 | 125 | Q9NPI8 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 30668 | Q9NPI8 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 133639 | Q9NPI8 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 3887 | Q9NPI8 | Espacenet |
| EP 3849565 A1 | 2021-07-21 | 125 | Q9NPI8 | Espacenet |
| US 11047010 B2 | 2021-06-29 | 2378 | Q9NPI8 | Espacenet |
| US 10865447 B2 | 2020-12-15 | 2378 | Q9NPI8 | Espacenet |
| JP 2020517720 A | 2020-06-18 | 58 | Q9NPI8 | Espacenet |
1 to 10 of 26
See all 26 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants834
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FANCF papers | Newest fiscal year |
|---|---|---|---|
| R01HL052725 | Molecular Pathogenesis of Fanconi Anemia | 15 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 14 | 2025 |
| ZIACP010144 | Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes | 13 | 2025 |
| ZIAAG000688 | Investigate the DNA damage response pathway of Fanconi anemia and BRCA proteins | 11 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 10 | 2025 |
| RM1HG009490 | Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease | 10 | 2025 |
| ZIAHG000029 | Fanconi Anemia: Genotype-Phenotype Correlations | 9 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 8 | 2025 |
| R35GM118062 | Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics | 8 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 7 | 2025 |
1 to 10 of 834Source NIH's project files
See all 834 nih grantsPapers1,147
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Micronuclei: origins, assays, mechanisms, diseases and treatments. | Signal Transduct Target Ther | 2026 | 41888103 | PubTator, text mining | PubMed |
| Unraveling cellular longevity pathways in poultry under heat stress: functional and computational characterization of the adaptogenic formulation Phytocee™. | In Silico Pharmacol | 2026 | 41852713 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens identify the EXO1-CAF-1 pathway suppressing R-loop-associated DNA damage. | Nucleic Acids Res | 2026 | 41841497 | PubTator, text mining | PubMed |
| Prognostic Significance of DNA Repair Gene mRNA Expression in Early-Stage Breast Cancer: Insights into Clinical Relevance. | Oncol Res | 2026 | 41799499 | PubTator, text mining | PubMed |
| Advances in Engineered Virus-Like Particles for Genome Editing and Therapy. | BioDrugs | 2026 | 41733889 | PubTator, text mining | PubMed |
| Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort. | Commun Med (Lond) | 2026 | 41526458 | PubTator, text mining | PubMed |
| Integrating CRISPR/Cas technology with clinical trials: Principles, progress and challenges. | Asian J Pharm Sci | 2025 | 41809894 | PubTator, text mining | PubMed |
| CSRNP1 Promotes Apoptosis and Mitochondrial Dysfunction via ROS-Mediated JNK/p38 MAPK Pathway Activation in Hepatocellular Carcinoma. | Oncol Res | 2025 | 41502527 | PubTator, text mining | PubMed |
| AI-driven advances in plant biotechnology: sharpening the edge of plant tissue culture and genome editing. | Front Plant Sci | 2025 | 41451278 | PubTator, text mining | PubMed |
| TSN Disrupts Fanconi Anemia Pathway Activation Through JAK/STAT1-Mediated Transcriptional Repression of FA Core Subunits in Bladder Cancer. | Dose Response | 2025 | 41346410 | PubTator, text mining | PubMed |
1 to 10 of 1,147
See all 1,147 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2188
GET https://conductscience.org/api/genes/v1/2188/patents?page=2